[1] 于炳旗, 张刚, 王晓春, 陈保平, 李中. 甲状腺癌75例临床治疗分析 [J]. 河北职工医学院学报 2008.doi:10.3969/j.issn.1674-490X.2008.04.007
[2] Cvejic D, Savin S, Petrovic I. Galectin-3 and proliferating cell nuclear antigen(PCNA)expressed in papillary thyroid carcinoma [J]. Experimental Oncology 2005, 27(03).
[3] Augustynowicz A, Dzieciol J, Barwijuk Machala M, Dadan J, Puchalski Z, Sulkowski S. [J]. Folia histochemica et cytobiologica 2004.
[4] Lipponen P K, Ekelinen M J. Cell proliferation of transitional cell Bladder tumor's determined by PCNA/cyclin immunostraining and its prognostic value [J]. British Journal of Cancer 1992, 66.
[5] Leung D W, Cachianes G, Kuang W T. Vascular endothelial growth factor is a secreted angiognic mitogen [J]. Science 1989, 246.
[6] Tuttle R M, Fleisher M, Francis G L. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short term TSH stimulation [J]. Journal of Clinical Endocrinology and Metabolism 2002, 87(04).
[7] Van Hoeven Kit, Menende Botet. Estrogen and progesterone receptor content was in human thyroid disease [J]. American Journal of Clinical Pathology 1993, 99(02). |
